George Parks

Director, Downstream Process Development at Takeda Pharmaceuticals AG

Speaker

George Parks has more than 25 years of experience in the pharmaceutical and biotechnology industries, specializing in downstream biotherapeutics process development. He leads a team responsible for downstream development across early- and late-stage programs. He plays a key role in advancing platform process development and strategy. His expertise spans monoclonal antibodies, fusion proteins, ADCs, and bispecifics. He has supported multiple regulatory filings, led process characterization and validation efforts, driven innovation initiatives, and led & contributed to CMC teams.